CN1073418C - 白细胞介素－8生成抑制剂 - Google Patents

白细胞介素－8生成抑制剂 Download PDF

Info

Publication number
CN1073418C
CN1073418C CN94190812.7A CN94190812A CN1073418C CN 1073418 C CN1073418 C CN 1073418C CN 94190812 A CN94190812 A CN 94190812A CN 1073418 C CN1073418 C CN 1073418C
Authority
CN
China
Prior art keywords
use according
quinolone
disease
general formula
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN94190812.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN1117268A (zh
Inventor
松田隆秀
大和田滋
牟田弘
相原美纪
滝泽寿男
今川健一
菊地干雄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of CN1117268A publication Critical patent/CN1117268A/zh
Application granted granted Critical
Publication of CN1073418C publication Critical patent/CN1073418C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
CN94190812.7A 1993-10-21 1994-10-17 白细胞介素－8生成抑制剂 Expired - Lifetime CN1073418C (zh)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
JP263418/1993 1993-10-21
JP263419/93 1993-10-21
JP263419/1993 1993-10-21
JP263418/93 1993-10-21
JP26341793 1993-10-21
JP263417/1993 1993-10-21
JP26341893 1993-10-21
JP263417/93 1993-10-21
JP26341993 1993-10-21
JP89641/94 1994-04-27
JP89641/1994 1994-04-27
JP8964194 1994-04-27
PCT/JP1994/001739 WO1995011026A1 (en) 1993-10-21 1994-10-17 Carbostyril derivative for inhibiting production of interleukin-8

Publications (2)

Publication Number Publication Date
CN1117268A CN1117268A (zh) 1996-02-21
CN1073418C true CN1073418C (zh) 2001-10-24

Family

ID=27467652

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94190812.7A Expired - Lifetime CN1073418C (zh) 1993-10-21 1994-10-17 白细胞介素－8生成抑制剂

Country Status (14)

Country Link
US (1) US5637597A (Direct)
EP (1) EP0674515B1 (Direct)
JP (1) JP2839847B2 (Direct)
KR (1) KR100191191B1 (Direct)
CN (1) CN1073418C (Direct)
AT (1) ATE184793T1 (Direct)
AU (1) AU683697B2 (Direct)
CA (1) CA2150546C (Direct)
DE (1) DE69420832T2 (Direct)
DK (1) DK0674515T3 (Direct)
ES (1) ES2138092T3 (Direct)
GR (1) GR3032091T3 (Direct)
TW (1) TW296983B (Direct)
WO (1) WO1995011026A1 (Direct)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR004214A1 (es) * 1995-10-12 1998-11-04 Otsuka Pharma Co Ltd Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
DE10029404B4 (de) * 2000-06-15 2009-10-29 Jagotec Ag Arzneiformulierung enthaltend Ciclosporin und deren Verwendung
FR2812548B1 (fr) * 2000-08-01 2002-09-20 Sanofi Synthelabo Utilisation de derives de quinolein-2(1h)-one ou un de leurs sels pharmaceutiquement acceptable pour la preparation d'un medicament destine au traitement de l'insuffisance renale
US7408078B2 (en) * 2002-10-08 2008-08-05 Wyeth Anthranilic acid derivatives useful in treating infection with hepatitis C virus
US7879877B2 (en) * 2003-07-30 2011-02-01 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives for accelerating salivation
TWI340650B (en) * 2004-01-21 2011-04-21 Otsuka Pharma Co Ltd Amine saly of carbostyril derivative
MY149159A (en) 2005-11-15 2013-07-31 Hoffmann La Roche Method for treating joint damage
WO2009022674A1 (en) * 2007-08-10 2009-02-19 Otsuka Pharmaceutical Co., Ltd. Medical composition containing rebamipide
KR101104634B1 (ko) * 2009-08-25 2012-01-12 한림제약(주) 레바미피드를 포함하는 류마티스 관절염 예방 또는 치료용 약학 조성물
KR101182114B1 (ko) * 2010-03-05 2012-09-12 한림제약(주) 유효성분으로서 레바미피드를 함유하는 골관절염 예방 또는 치료용 약학 조성물
US9248196B2 (en) 2011-02-25 2016-02-02 Nuformix Limited Rebamipide complexes and cocrystals
EP2688552A1 (en) 2011-03-24 2014-01-29 Otsuka Pharmaceutical Co., Ltd. A pharmaceutical composition for treating a disease in the oral cavity comprising rebamipide
JP6294773B2 (ja) * 2014-06-27 2018-03-14 株式会社ナールスコーポレーション 口腔粘膜疾患の予防または治療用経口製剤
WO2022128054A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for fighting inflammatory conditions of human skin (iv)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992021342A1 (en) * 1991-06-07 1992-12-10 Otsuka Pharmaceutical Co., Ltd. Antidiabetic

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578381A (en) * 1982-07-05 1986-03-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
JPS63119467A (ja) * 1987-10-21 1988-05-24 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
JPH02178227A (ja) * 1988-12-28 1990-07-11 Otsuka Pharmaceut Co Ltd 腎炎治療剤
JP2812998B2 (ja) * 1989-08-14 1998-10-22 大塚製薬 株式会社 胃炎治療剤
ES2138971T3 (es) * 1991-07-03 2000-02-01 Otsuka Pharma Co Ltd Regulador de la apoptosis.
TW227558B (Direct) * 1992-05-14 1994-08-01 Otsuka Pharma Co Ltd
JP2872546B2 (ja) * 1992-11-26 1999-03-17 大塚製薬株式会社 腸粘膜障害保護剤
AU5715994A (en) * 1992-12-24 1994-07-19 Otsuka Pharmaceutical Co., Ltd. Psoriasis remedy
AU672288B2 (en) * 1993-03-02 1996-09-26 Akira Matsumori Rejection inhibitor for transplants and IL-1 production inhibitor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992021342A1 (en) * 1991-06-07 1992-12-10 Otsuka Pharmaceutical Co., Ltd. Antidiabetic

Also Published As

Publication number Publication date
AU683697B2 (en) 1997-11-20
CN1117268A (zh) 1996-02-21
CA2150546A1 (en) 1995-04-27
JPH0812578A (ja) 1996-01-16
TW296983B (Direct) 1997-02-01
ATE184793T1 (de) 1999-10-15
KR100191191B1 (ko) 1999-06-15
KR950703957A (ko) 1995-11-17
WO1995011026A1 (en) 1995-04-27
EP0674515B1 (en) 1999-09-22
DK0674515T3 (da) 1999-12-20
DE69420832D1 (de) 1999-10-28
EP0674515A1 (en) 1995-10-04
AU7864194A (en) 1995-05-08
CA2150546C (en) 2004-11-09
JP2839847B2 (ja) 1998-12-16
DE69420832T2 (de) 2000-01-13
US5637597A (en) 1997-06-10
ES2138092T3 (es) 2000-01-01
GR3032091T3 (en) 2000-03-31

Similar Documents

Publication Publication Date Title
CN1073418C (zh) 白细胞介素－8生成抑制剂
CN1267098C (zh) 将脱碳乙氧基氯雷他定或其可药用盐用于制备治疗过敏性鼻炎的药物的用途
CN1170540C (zh) 茶碱缓释片
JP6837486B2 (ja) 加齢に関連する認知障害及び神経炎症を予防及び／又は治療する方法
JPH07330628A (ja) 薬剤組成物及びこれを用いた治療法
TWI794885B (zh) 全身紅斑性狼瘡之治療
CN1023191C (zh) 生产持续释放异丁丙苯酸制剂的方法
US4910224A (en) Method of modifying the lipid structure and function of cell membranes and pharmaceutical compositions for use therein
JP4394686B2 (ja) 唾液分泌促進用医薬組成物およびその使用
JP2013199506A (ja) 処置方法
CN1217721A (zh) 治疗或预防间质膀胱炎的方法
CN1118991A (zh) 白三烯-1抑制剂
CN1204881C (zh) 烯丙胺衍生物在制备治疗幽门螺杆菌感染和相关疾病的药物方面的用途
RU2341309C1 (ru) Средство для профилактики воздействия магнитных бурь на больных с ишемической болезнью сердца и гипертонической болезнью и способ его применения
EP4511031A1 (en) Treatment of neutrophilic dermatoses
US5387614A (en) Use of sigma receptor ligands as salivary gland stimulants
MXPA06006831A (es) Uso de estatinas para el tratamiento del sindrome metabolico.
HUE028220T2 (en) The use of benzidamine in the treatment of p40-dependent diseases
EP1032401B1 (fr) Procede d'inhibition de la production cellulaire de cytokines
JP2010111581A (ja) ドーパミンｄ２様受容体アゴニストを有効成分とする医薬及びスクリーニング方法
CN1305379A (zh) 治疗方法
CN1217668C (zh) 红霉素衍生物的缓释制剂
CN120000645A (zh) 白塞综合征的治疗
WO2008015763A1 (fr) Formulation médicamenteuse contenant un médicament fibrate et procédé pour la produire
JPH0881366A (ja) 多動性障害治療剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CX01 Expiry of patent term

Expiration termination date: 20141017

Granted publication date: 20011024